MORRISON SCOTT W exercised options at TARSUS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/16/2026ACC: 0001662426-26-000004
Director
Since Oct 2022
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.95K acquired · 2.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.95K
Price / share
—
Trade value
—
% of position
63.1%
6/12/2026
4.68K→7.64K
Total
Net shares
+2.95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2026 | M · Option Exercise | +2.95K | — | — | 63.1% | 4.68K | 7.64K |
| Total | +2.95K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.95K shares
Shares
−2.95K
Strike price
Held after
0.00
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.95K shares | 6/12/2026 | M · Option Exercise | −2.95K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.02K
Total
6.02K indirect6.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.02K | Indirect |
| Total | 6.02K | 6.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported